Abiralieva 250mg Tablet

Product Description

       Abiralieva 250mg Tablet is an anti-cancer medication containing Abiraterone acetate, primarily used to treat metastatic castration-resistant prostate cancer (mCRPC). It belongs to the class of drugs called androgen biosynthesis inhibitors, which work by blocking the production of androgens (male hormones like testosterone) that fuel the growth of prostate cancer cells.

Brand Name: Abiralieva

Composition: Abiraterone acetate

Mechanism of Action:

It inhibits the CYP17A1 enzyme, which is crucial for androgen (testosterone) production in the adrenal glands, testes, and prostate tumor tissues. By blocking this enzyme, it significantly reduces androgen levels, depriving prostate cancer cells of the hormones they need to grow. This is particularly effective in treating metastatic castration-resistant prostate cancer (mCRPC).

Uses:

      Metastatic Castration-Resistant Prostate Cancer (mCRPC)

      Metastatic High-Risk Castration-Sensitive Prostate Cancer (mCSPC)

Side Effects:

      Swelling

      Hypokalemia (low potassium)

      Hypertension (high blood pressure)

      Elevated liver enzymes

      Fatigue

      Joint pain

      Nausea

      Vomiting

      Anemia

      Diarrhea